News: Daiichi Sankyo Co Ltd (4568.T)

4568.T on Tokyo Stock Exchange

1,842JPY
27 Aug 2014
Price Change (% chg)

¥2 (+0.11%)
Prev Close
¥1,840
Open
¥1,846
Day's High
¥1,856
Day's Low
¥1,832
Volume
1,373,300
Avg. Vol
1,842,062
52-wk High
¥2,007
52-wk Low
¥1,606

Search Stocks
Select another date:

Sun, Aug 10 2014

INDIA PRESS-Sun Pharma banks on Daiichi Sankyo to crack Japan market-Economic Times

Note: Reuters has not verified this story and does not vouch for its accuracy. (Compiled by Aby Jose Koilparambil in Bangalore)

Update-Moody's affirms Daiichi Sankyo's A1 rating; outlook stable

For the full text of this story please click the following link:

Targeted Plexxikon drug helps ease pain from rare joint disease

CHICAGO - An experimental cancer drug being developed by Plexxikon, a unit of Daiichi Sankyo, appears to ease pain and swelling in patients with a rare joint disease caused by a genetic mutation, researchers said on Wednesday.

Targeted Plexxikon drug helps ease pain from rare joint disease

CHICAGO, May 14 - An experimental cancer drug being developed by Plexxikon, a unit of Daiichi Sankyo, appears to ease pain and swelling in patients with a rare joint disease caused by a genetic mutation, researchers said on Wednesday.

INDIA PRESS-Daiichi Sankyo contests Andhra Pradesh High Court fiat on Ranbaxy deal-Economic Times

Note: Reuters has not verified this story and does not vouch for its accuracy. (Compiled by Aby Jose Koilparambil in Bangalore)

India's Sun Pharma to buy struggling Ranbaxy for $3.2 billion as Daiichi Sankyo retreats

TOKYO/MUMBAI - India's Sun Pharmaceutical Industries Ltd has agreed to buy generic drugmaker Ranbaxy Laboratories Ltd for $3.2 billion, betting it can fix factory quality glitches that plagued the current owner, Japan's Daiichi Sankyo Co , and got Ranbaxy India-made drugs barred from the United States. | Video

Nikkei falls to 1-week low, SoftBank dives on selloff in U.S. tech stocks

* SoftBank dives in wake of selloff in U.S. tech stocks * Daiichi Sankyo soars after Sun Pharma buys Indian unit Ranbaxy * U.S. jobs data positive but overshadowed by Wall Street slide By Ayai Tomisawa TOKYO, April 7 - Japan's Nikkei share average tumbled to a one-week low on Monday morning after a slide on Wall Street overshadowed encouraging U.S. jobs data, and index heavyweight SoftBank Corp dived in the wake of a sell-off in U.S. tech names. Traders said SoftBa

Daiichi Sankyo says Sun Pharma to buy Indian unit Ranbaxy

TOKYO, April 7 - Japan's Daiichi Sankyo Co Ltd said on Monday Sun Pharmaceutical Industries Ltd will buy its Indian unit Ranbaxy Laboratories Ltd , creating the world's fifth-largest speciality generics company.

Select another date:
Search Stocks